Beacon Pointe Advisors, LLC Eli Lilly & CO Transaction History

Beacon Pointe Advisors, LLC

$8.89 Billion
Q1 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 44,205 shares of LLY stock, worth $40 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

44,205

Previous 66,111 33.14%

Holding current value

$40 Million

Previous $38.5 Million 10.76%

% of portfolio

0.39%

Previous 0.47%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $13 Million - $17.4 Million	-21,906 Reduced 33.14%	44,205 $34.4 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $69,325 - $81,725	132 Added 0.2%	66,111 $38.5 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $5.28 Million - $7.27 Million	12,136 Added 22.54%	65,979 $35.4 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $5.97 Million - $7.98 Million	-17,010 Reduced 24.01%	53,843 $25.3 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $9.51 Million - $11.2 Million	30,607 Added 76.05%	70,853 $24.3 Million

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $3.38 Million - $3.94 Million	10,506 Added 35.33%	40,246 $14.7 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $2,964 - $3,378	-10 Reduced 0.03%	29,740 $9.62 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $227,164 - $266,725	815 Added 2.82%	29,750 $9.65 Million
Q1 2022 May 17, 2022	BUY	$234.69 - $291.66 $2.19 Million - $2.72 Million	9,317 Added 47.49%	28,935 $8.29 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $192,021 - $238,300	-854 Reduced 4.17%	19,618 $5.42 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.78 Million - $2.19 Million	8,033 Added 64.58%	20,472 $4.73 Million
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $882,528 - $1.14 Million	4,888 Added 64.73%	12,439 $2.86 Million
Q1 2021 May 18, 2021	SELL	$164.32 - $212.72 $86,925 - $112,528	-529 Reduced 6.55%	7,551 $1.41 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $180,948 - $239,437	1,387 Added 20.72%	8,080 $1.36 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $90,948 - $105,198	-622 Reduced 8.5%	6,693 $991,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $150,334 - $180,926	1,102 Added 17.74%	7,315 $1.2 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $218,099 - $269,945	1,832 Added 41.82%	6,213 $861,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $24,698 - $30,591	-231 Reduced 5.01%	4,381 $578,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $38,444 - $41,817	-360 Reduced 7.24%	4,612 $517,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $4,985 - $5,819	45 Added 0.91%	4,972 $553,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $27,827 - $32,755	-250 Reduced 4.83%	4,927 $638,000
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $548,244 - $614,199	5,177 New	5,177 $600,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Eli Lilly & CO Transaction History